Viewing Study NCT00006104


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2025-12-28 @ 4:04 PM
Study NCT ID: NCT00006104
Status: COMPLETED
Last Update Posted: 2012-08-14
First Post: 2000-08-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer
Sponsor: Vanderbilt-Ingram Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module